Skip to content
20-F

Annual Report (Foreign)

Pharvaris N.V. PHVS

0000950170-25-051347

← back to feed
Filed
Apr 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Dec 31, 2024 54.38M sh
Total Liabilities FY 2024 · Dec 31, 2023 €14.65M
Total Assets FY 2024 · Dec 31, 2023 €398.69M
Operating Cash Flow FY 2024 · Dec 31, 2022 −€67.16M
Eps Diluted FY 2024 · Dec 31, 2022 −€2.27
Eps Basic FY 2024 · Dec 31, 2022 −€2.27
Rd Expense FY 2024 · Dec 31, 2022 €57.38M
Net Income FY 2024 · Dec 31, 2022 −€76.33M
Operating Income FY 2024 · Dec 31, 2022 −€75.65M
Cash And Equivalents FY 2024 · Dec 31, 2021 €209.35M
Stockholders Equity restated FY 2024 · Dec 31, 2021 €204.95M